Retour
Fourchette du Jour
23,50 €
25,08 €
Fourchette 52 Semaines
4,66 €
32,63 €
Volume
131 559
Moyenne 50J / 200J
26,59 €
/
19,96 €
Clôture Précédente
23,44 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -22,2 | 0,3 |
| P/B | 2,9 | 3,0 |
| ROE % | -12,2 | 3,7 |
| Net Margin % | -106,4 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
39,00 €
+61.1%
Low: 28,00 €
High: 60,00 €
BPA Prévisionnel
-1,64 €
CA Est.
68,30M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-3,61 €
-5,23 € – -2,04 €
|
84,30M | 2 |
| FY2029 |
-3,52 €
-5,09 € – -1,99 €
|
50,08M | 2 |
| FY2028 |
-2,73 €
-3,63 € – -1,76 €
|
63,70M | 4 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-09 | -0,25 € | -0,24 € | +5,6% |
| 2025-11-10 | 0,19 € | -0,09 € | -147,4% |
| 2025-08-11 | -0,05 € | -0,56 € | -1020,0% |
| 2025-05-15 | -0,38 € | -0,49 € | -28,9% |
| 2025-03-27 | -0,69 € | -0,64 € | +7,2% |
| 2024-11-21 | -0,83 € | -8,40 € | -912,0% |
| 2023-12-31 | N/A | 2,05 € | — |
| 2023-09-30 | N/A | -0,56 € | — |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Debt/Equity of 0,06 — conservative balance sheet
Generating 109,67M in free cash flow
PEG of 0,30 suggests growth is underpriced
Capital efficient — spends only 1,13% of revenue on capex
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)4174,51%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-12,19%
ROIC-14,94%
Net Margin-106,37%
Op. Margin-175,83%
Sécurité
Debt / Equity
0,06
Current Ratio4,73
Interest Coverage0,00
Valorisation
P/E Ratio
-22,24
Forward P/EN/A
P/B Ratio2,85
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4174,51% | Revenue Growth (3Y) | 1644,45% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 45,95M | Net Income (TTM) | -48,88M |
| ROE | -12,19% | ROA | -8,20% |
| Gross Margin | 100,00% | Operating Margin | -175,83% |
| Net Margin | -106,37% | Free Cash Flow (TTM) | 109,67M |
| ROIC | -14,94% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,06 | Current Ratio | 4,73 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -22,24 | Forward P/E | N/A |
| P/B Ratio | 2,85 | P/S Ratio | 23,66 |
| PEG Ratio | 0,30 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 15,92 | Fwd Earnings Yield | N/A |
| FCF Yield | 10,09% | ||
| Market Cap | 1,09B | Enterprise Value | 990,09M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 45,95M | 1,08M | 151 000,0 | 0,0 |
| Net Income | -48,88M | -71,80M | 4,18M | -27,68M |
| EPS (Diluted) | -1,10 | -7,26 | 0,03 | -1,42 |
| Gross Profit | 45,95M | 1,08M | 151 000,0 | 0,0 |
| Operating Income | -80,80M | -80,82M | 2,08M | -27,97M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 596,19M | 456,55M | 130,87M | 36,12M |
| Total Liabilities | 214,26M | 36,51M | 169,24M | 80,32M |
| Shareholders' Equity | 381,93M | 420,05M | -38,37M | -44,20M |
| Total Debt | 23,63M | 25,48M | 12,57M | 710 000,0 |
| Cash & Equivalents | 120,72M | 238,20M | 88,48M | 30,61M |
| Current Assets | 410,96M | 356,82M | 112,68M | 31,89M |
| Current Liabilities | 86,93M | 12,85M | 6,91M | 5,54M |